THE HIDDEN TRUTH ABOUT FORXIGA SIDE-EFFECTS

Sdílet
Vložit
  • čas přidán 9. 07. 2024
  • Dapagliflozin (brand name Forxiga) is a Sodium-glucose co-transporter 2 (SGLT2) inhibitor and is prescribed for adults with type 2 diabetes mellitus to improve their diabetic control when diet and exercise alone are not enough for good control. It can also be used to treat heart failure and chronic kidney disease (CKD).
    This video will explain everything you needs to know about SGLT2 inhibitors, including common and uncommon side-effects such as Thrush, Fourniers Gangrene and Diabetic Ketoacidosis (DKA). We will also give you advice about how to manage some of the side-effects.
    CZcams video link to Metformin: • GLUCOPHAGE SHOCKING SI...
    In Diabetes, SGLT2 inhibitors are given on their own in patients for whom the use of metformin is considered inappropriate due to reasons of intolerance or contraindications. SGLT2 inhibitors can also be given with other glucose-lowering drugs, including insulin, when these drugs do not provide adequate diabetic control.
    The SGLT2 inhibitor-containing medicines marketed in the UK are Forxiga▼ (dapagliflozin), Xigduo▼ (dapagliflozin and metformin), Jardiance▼ (empagliflozin), and Synjardy▼ (empagliflozin and metformin) Edistride ▼(dapagliflozin),
    Ebymect ▼(dapagliflozin/metformin), Qtern ▼(dapagliflozin/ saxagliptin), Invokana▼ (canagliflozin), Vokanamet▼ (canagliflozin/metformin), Glyxambi▼ (empagliflozin/linagliptin), Steglatro▼ (ertugliflozin), Segluromet▼ (ertugliflozin/metformin), and Steglujan▼ (ertugliflozin/sitagliptin)
    #dapagliflozin #sglt2inhibitors #type2diabetes
    Timeline:
    00:00 Introduction
    01:03 What is Dapagliflozin?
    02:16 How do you take it?
    02:51 What are the common side-effects?
    06:11 What are the uncommon side-effects?
    09:10 What are the cautions with other medicines?
    10:39 Do you stop taking SGLT2 inhibitors if you become unwell?
    11:19 What is the 'Sick Day Guidance'?
    Clinical data:
    UK Drug Safety update on SGLT2 inhibitors and reports of Fournier’s gangrene:
    www.gov.uk/drug-safety-update...
    and the FDA Safety announcement:
    www.fda.gov/drugs/drug-safety...
    UK Drug Safety update about SGLT2 inhibitors and Risk of Diabetic Ketoacidosis
    www.gov.uk/drug-safety-update...
    UK Drug Safety Update on SGLT2 inhibitors and increased Risk of Lower-limb Amputation (mainly toes):
    www.gov.uk/drug-safety-update...
    Disclaimer: The videos posted will be for general informational purposes only. They should not be used to self-diagnose or a substitute for a medical exam, cure, treatment, diagnosis, prescription, or recommendation. You should not make any changes to your health regimen or diet before first consulting a doctor.

Komentáře • 6

  • @kevinwellwrought2024
    @kevinwellwrought2024 Před 19 hodinami

    Is Farxiga recommendable for reducing proteinuria in non-diabetes patients with normal GFR?

  • @MG-wp4gl
    @MG-wp4gl Před 2 měsíci +6

    SEEMS AWFUL STUFF - TO MANY HORENDOUS SIDE EFFECTS.

  • @RavenWolfDrum69
    @RavenWolfDrum69 Před 3 měsíci +4

    Feck that med

  • @BrendaKing-zs9tb
    @BrendaKing-zs9tb Před 2 měsíci +4

    My diabetic type two friend she tajes farziga and her glucose is always like 238 in fasted morning and depending on what she eats her glucose goes up to 380 450.........so what good is the farziga doing for her